These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Treatment of disequilibrium and nausea in the SRI discontinuation syndrome. Schechter JO J Clin Psychiatry; 1998 Aug; 59(8):431-2. PubMed ID: 9721826 [No Abstract] [Full Text] [Related]
11. Withdrawal from paroxetine can be severe, warns FDA. Tonks A BMJ; 2002 Feb; 324(7332):260. PubMed ID: 11823353 [No Abstract] [Full Text] [Related]
12. Withdrawal after discontinuation of paroxetine. Arya DK Aust N Z J Psychiatry; 1996 Oct; 30(5):702. PubMed ID: 8902183 [No Abstract] [Full Text] [Related]
13. Persistent tardive rebound panic disorder, rebound anxiety and insomnia following paroxetine withdrawal: a review of rebound-withdrawal phenomena. Bhanji NH; Chouinard G; Kolivakis T; Margolese HC Can J Clin Pharmacol; 2006; 13(1):e69-74. PubMed ID: 16456219 [TBL] [Abstract][Full Text] [Related]